Vascarta and CUNY collaborate to improve chemotherapy efficacy and safety
SUMMIT, N.J., Jan. 13, 2025 /PRNewswire/ -- Vascarta has obtained the exclusive rights to a novel method of creating more effective cancer therapies with fewer side effects applying new and
 
	


 
	 
				



